Striatal dopamine transporter availability with [123I]β-CIT SPECT is unrelated to gender or menstrual cycle
- First Online:
- 70 Downloads
The effect of gender and female menstrual cycle on human striatal dopamine transporters (DATs) was investigated with single-photon emission computed tomography (SPECT) using the ligand 2β-carbomethoxy-3β-(4-[123I]iodophenyl)tropane.
Ten female subjects aged 18–40 years (25.3±7.3 years) were scanned twice during the early follicular and the mid-luteal phases to detect any hormone-mediated changes in DAT availability in the striatum or serotonin transporter (SERT) availability in brainstem–diencephalon. Plasma estradiol and progesterone levels were obtained at the time of SPECT and confirmed the expected increases from the follicular to the luteal phases. Finally, in a post hoc analysis of a previously published healthy-subject sample, striatal DAT availability was compared between 70 male and 52 female subjects who ranged in age from 18 to 88 years.
In the ten menstrual cycle subjects, DAT availability (V3″) in striatum and SERT availability in brainstem–diencephalon did not differ between follicular and luteal phases. Moreover, change in V3″ for striatum or brainstem–diencephalon was uncorrelated with change in plasma estradiol or progesterone from the follicular to the luteal phase. In the larger healthy-subject sample, there was no significant effect of gender or the interaction of age and gender on striatal V3″.
These findings suggest that in using DAT or SERT ligands in the study of neuropsychiatric disorders, matching of female subjects according to a menstrual cycle phase is unnecessary. Although the present investigation did not confirm previous reports of gender differences in striatal DAT availability, controlling for gender in such studies still seems advisable.
Keywords[123I]β-CIT Dopamine transporter Serotonin transporter SPECT Gender Women Menstrual cycle
- Carroll FI, Rahman MA, Abraham P, Parham K, Lewin AH, Dannals RF, Shaya E, Scheffel U, Wong DF, Boja JW, Kuhar MJ (1991) [123I]3β-(4-iodophenyl)tropan-2β-carboxylic acid methyl ester (RTI-55), a unique cocaine receptor ligand for imaging the dopamine and serotonin transporters in vivo. Med Chem Res 1:289–294Google Scholar
- Gardiner SA, Morrison MF, Mozley PD, Mozley LH, Brensinger C, Bilker W, Newberg A, Battistini M (2004) Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women. Am J Geriatr Psychiatry 12:621–630CrossRefPubMedGoogle Scholar
- Innis RB, Seibyl JP, Scanley BE, Laruelle M, Abi-Dargham A, Wallace E, Baldwin RM, Zea-Ponce Y, Zoghbi S, Wang S, Gao Y, Neumeyer JL, Charney DS, Hoffer PB, Marek KL (1993) Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc Natl Acad Sci U S A 90:11965–11969PubMedCrossRefGoogle Scholar
- Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, Al-Tikriti MS, Sybirska EH, Zimmermann R, Wisniewski G, Neumeyer JL, Milius RA, Wang S, Smith EO, Roth RH, Charney DS, Hoffer PB, Innis RB (1993) SPECT imaging of dopamine and serotonin transporters with [123I]β-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 13:295–309CrossRefPubMedGoogle Scholar
- Laruelle M, Wallace E, Seibyl JP, Baldwin RM, Zea-Ponce Y, Zoghbi SS, Neumeyer JL, Charney DS, Hoffer PB, Innis RB (1994) Graphical, kinetic, and equilibrium analyses of in vivo [123I]β-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 14:982–994PubMedGoogle Scholar
- Malison RT, Price LH, Berman RM, van Dyck CH, Pelton GH, Carpenter LL, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS (1998b) Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44:1090–1098CrossRefPubMedGoogle Scholar
- Metcalf MG, Mackenzie JA (1980) Incidence of ovulation in young women. J Biosoc Sci:345–352Google Scholar
- Neumeyer JL, Wang S, Milius RA, Baldwin RM, Zea-Ponce Y, Hoffer PB, Sybirska E, Al-Tikriti M, Charney DS, Malison RT, Laruelle MA, Innis RB (1991) [123I]-2-β-Carbomethoxy-3-β-(4-iodophenyl)-tropane (β-CIT): high affinity SPECT radiotracer of monoamine reuptake sites in brain. J Med Chem 34:3144–3146CrossRefPubMedGoogle Scholar
- Seibyl JP, Wallace E, Smith EO, Stabin M, Baldwin RM, Zea-Ponce Y, Gao Y, Zhang YW, Neumeyer JL, Zubal IG, Charney DS, Hoffer PB, Innis RB (1994) Whole-body biodistribution, radiation absorbed dose, and brain SPECT imaging with iodine-123-β-CIT in healthy human subjects. J Nucl Med 35:764–770PubMedGoogle Scholar
- Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Fussell B, Smith EO, Charney DS, van Dyck CH, Hoffer PB, Innis RB (1995) Decreased single-photon emission computed tomographic [123I]β-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 38:589–598CrossRefPubMedGoogle Scholar
- Sorenson JA, Phelps ME (1987) Physics in nuclear medicine. Saunders, PhiladelphiaGoogle Scholar
- Wong DF, Broussolle EP, Wand G, Villemagne V, Dannals RF, Links JM, Zacur HA, Harris J, Naidu S, Braestrup C, Wagner HN, Gjedde A (1988) In vivo measurement of dopamine receptors in human brain by positron emission tomography: age and sex differences. Ann N Y Acad Sci 515:203–214PubMedCrossRefGoogle Scholar